You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
宜華健康(000150.SZ):達孜賽勒康終止收購玉山博愛70%股權
格隆匯 03-20 20:24

格隆匯3月20日丨宜華健康(000150.SZ)公佈,公司於2018年5月28日及2018年6月13日召開的第七屆董事會第二十次會議、2018年第五次臨時股東大會審議通過《關於公司子公司收購玉山縣博愛醫院有限公司70%股權暨關聯交易的議案》,達孜賽勒康醫療投資管理有限公司(“達孜賽勒康”)以1.043億元價格購買汕頭市宜鴻投資有限公司(“宜鴻投資”)所持玉山縣博愛醫院有限公司(“玉山博愛”)70%股權。

2018年5月28日,達孜賽勒康與宜鴻投資、玉山博愛、練習文、練習武、練海軍、黃良菊簽署《關於玉山縣博愛醫院有限公司之股權轉讓協議》。

2018年12月20日,宜鴻投資收到達孜賽勒康支付的股權轉讓款共計8512萬元,已達到股權轉讓協議約定的過户條件。

因宜鴻投資未按照股權轉讓協議的約定完成過户,以及公司經營發展需求,公司於2020年3月20日召開第七屆董事會第四十四次董事會審議通過《關於公司子公司終止收購玉山縣博愛醫院有限公司70%股權暨關聯交易的議案》,達孜賽勒康終止收購玉山博愛70%股權,並與對手方簽署《股權轉讓協議補充協議》,宜鴻投資將退回股權轉讓款,及承擔股權轉讓協議約定的“以已取得的股權轉讓款金額為基數按照每日萬分之五計算違約金”,即宜鴻投資需向達孜賽勒康退回股權轉讓款本金及違約金共計1.0453億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account